Klinikum der Universität München (LMU Klinikum)

SynthRAD2025 Grand Challenge dataset: Generating synthetic CTs for radiotherapy from head to abdomen (2025) Thummerer A, van der Bijl E, Galapon AJ, Kamp F, Savenije M, Muijs C, Aluwini S, et al. Journal article Implementation and clinical evaluation of an in-house thoracic auto-segmentation model for 0.35 T magnetic resonance imaging guided radiotherapy (2025) Delopoulos N, Marschner S, Lombardo E, Ribeiro MF, Rogowski P, Losert C, Winderl T, et al. Journal article Harmonizing organ-at-risk structure names using open-source large language models (2025) Thummerer A, Maspero M, van der Bijl E, Corradini S, Belka C, Landry G, Kurz C Journal article Oligometastatic disease and stereotactic radiotherapy: Key aspects and considerations Oligometastasierung und Stereotaxie: Schlüsselaspekte und Überlegungen (2025) Ehret F, Corradini S, Lützen U Journal article, Review article Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment Recommendations (2025) Untch M, Banys-Paluchowski M, Brucker SY, Denkert C, Fasching P, Haidinger R, Harbeck N, et al. Journal article, Review article "Is this sedation?" - a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care (2025) Krauss SH, Rémi C, Bausewein C, Bazata J, Grebe A, Ostgathe C, Schildmann J, Schildmann E Journal article Machine learning based assessment of hoarseness severity: a multi-sensor approach centered on high-speed videoendoscopy (2025) Schraut T, Schützenberger A, Arias Vergara T, Kunduk M, Echternach M, Dürr S, Werz J, Döllinger M Journal article Notfallpharmakologische Relevanz der EMA-Warnmeldung zu Metamizol (2025) Heinmann A, Ittner KP, Koppenberg J, Mansberger P, Neubert A, Prückner S, Walter U Journal article Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025) Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching P, Harbeck N, et al. Journal article Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma (2025) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article